Original Cyclontane / ADK-638 patent trail
Authors not yet confirmed · 2003 · RU2196575C2; cited in later RU2674342C2
What does this source report?
The later patent cites this earlier Cyclontane development record. Original behavioral and toxicity comparisons require direct verification before numerical claims are reproduced.
- Population and setting
- Original experiments not independently recovered for this entry
- Evidence type
- Patent / reported experiments
- Preparation
- See the original report; formulation details require verification.
- Source language
- Russian
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Bibliographic lead only; neither potency ratios nor toxicity estimates from secondary accounts are treated as verified here.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Prior-art citation followed from the 2018 patent; original retrieval unsuccessful.
Recorded source-check date: 2026-10-03. This date does not imply a completed systematic review.
Cite and trace this record
Original source: Author unconfirmed. Original Cyclontane / ADK-638 patent trail RU2196575C2; cited in later RU2674342C2 2003.
Molekul research summary: https://molekul.io/research/adk-cyclontane-original-patent. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry